Caenorhabditis Intervention Testing Program (CITP) at the University of Oregon

俄勒冈大桥线虫病干预检测项目资金申请 与人类老龄化相关的健康挑战给社会带来了巨大的损失。身体和认知能力下降极限 老年人及其照顾者的生活质量。年龄增长是导致这种疾病的主要危险因素和可能原因。 癌症、糖尿病和神经退行性疾病。毫无疑问，促进健康老龄化 扩大对衰退和疾病的抵抗力应该是当前医学研究的主要目标。 幸运的是，衰老生物学领域已经取得了巨大的进步，科学有望成为 转化为临床前和临床科学。线虫等简单动物模型 优雅一直是这一成功的核心。许多基因和化学复合干预 调节衰老过程很可能在人类身上起到类似的作用。细菌性炎干预试验 计划(CITP)旨在利用这些独特的优势来确定并有力地测试广泛的 化合物具有潜在的寿命和延长健康寿命的效果。CITP由一个合作的科学机构组成 由三个密切互动的实验室组成的小组，他们协调测试药物干预措施 它们能够延长线虫的健康衰老和延长寿命。此应用程序是为了请求桥接 为非常成功的炎干预测试计划(CITP)提供资金，以填补 资金周期。

Caenorhabditis Intervention Testing Program at Oregon Bridge Funding Request Health challenges linked to human aging take a tremendous toll on society. Physical and cognitive decline limit the quality of life for the elderly and their caregivers. Aging is the major risk factor for, and possible cause of, cancer, diabetes, and neurodegenerative disease. Without question, the promotion of healthy aging with extended resistance to decline and disease should be a major objective of current medical research. Fortunately, tremendous progress has been made in the biology of aging field and the science is poised to be translated into preclinical and clinical science. Simple animals models such as the nematode Caenorhabditis elegans have been at the heart of this success. Many genes and chemical compound interventions that modulate aging processes are likely to act similarly in humans. The Caenorhabditis Intervention Testing Program (CITP) aims to capitalize upon these unique strengths to identify and robustly test a wide range of compounds for potential life and healthspan extending effects. The CITP consists of a co-operative scientific group involving three closely interacting laboratories who coordinately test pharmacological interventions for their ability to extend healthy aging and promote longevity in nematodes. This application is to request bridge funding for the highly successful Caenorhabditis Intervention Testing Program (CITP) to fill a gap between funding cycles.